News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
861,919 Results
Type
Article (87493)
Company Profile (807)
Press Release (773596)
Multimedia
Podcasts (176)
Webinars (28)
Section
Business (233078)
Career Advice (4140)
Deals (39802)
Drug Delivery (138)
Drug Development (91271)
Employer Resources (203)
FDA (18292)
Job Trends (17404)
News (397450)
Policy (39927)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (127)
Alliances (56980)
ALS (147)
Alzheimer's disease (1687)
Antibody-drug conjugate (ADC) (257)
Approvals (18326)
Artificial intelligence (506)
Autoimmune disease (93)
Automation (29)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (164)
Biotechnology (485)
Bladder cancer (137)
Brain cancer (53)
Breast cancer (514)
Cancer (4080)
Cardiovascular disease (354)
Career advice (3560)
Career pathing (38)
CAR-T (251)
CDC (57)
Cell therapy (698)
Cervical cancer (33)
Clinical research (75697)
Collaboration (1425)
Company closure (4)
Compensation (943)
Complete response letters (61)
COVID-19 (2961)
CRISPR (82)
C-suite (610)
Cystic fibrosis (140)
Data (4737)
Decentralized trials (2)
Denatured (63)
Depression (112)
Diabetes (459)
Diagnostics (7101)
Digital health (37)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (241)
Drug pricing (193)
Drug shortages (36)
Duchenne muscular dystrophy (205)
Earnings (98987)
Editorial (54)
Employer branding (25)
Employer resources (172)
Events (133216)
Executive appointments (996)
FDA (20832)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1284)
Gene editing (175)
Generative AI (52)
Gene therapy (558)
GLP-1 (1027)
Government (5390)
Grass and pollen (7)
Guidances (363)
Healthcare (20938)
HIV (48)
Huntington's disease (40)
IgA nephropathy (64)
Immunology and inflammation (247)
Immuno-oncology (21)
Indications (55)
Infectious disease (3210)
Inflammatory bowel disease (191)
Inflation Reduction Act (16)
Influenza (102)
Intellectual property (195)
Interviews (816)
IPO (17928)
IRA (59)
Job creations (5197)
Job search strategy (2865)
Kidney cancer (17)
Labor market (80)
Layoffs (642)
Leadership (36)
Legal (10148)
Liver cancer (92)
Longevity (13)
Lung cancer (585)
Lymphoma (269)
Machine learning (32)
Management (66)
Manufacturing (655)
MASH (145)
Medical device (14897)
Medtech (14922)
Mergers & acquisitions (22769)
Metabolic disorders (1174)
Multiple sclerosis (139)
NASH (23)
Neurodegenerative disease (234)
Neuropsychiatric disorders (63)
Neuroscience (2745)
NextGen: Class of 2025 (7687)
Non-profit (5096)
Now hiring (59)
Obesity (565)
Opinion (315)
Ovarian cancer (138)
Pain (170)
Pancreatic cancer (176)
Parkinson's disease (244)
Partnered (30)
Patents (426)
Patient recruitment (329)
Peanut (57)
People (66317)
Pharmaceutical (145)
Pharmacy benefit managers (28)
Phase I (23349)
Phase II (32848)
Phase III (24769)
Pipeline (2788)
Policy (298)
Postmarket research (3554)
Preclinical (10535)
Press Release (72)
Prostate cancer (204)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (692)
Real estate (7422)
Recruiting (79)
Regulatory (28086)
Reports (65)
Research institute (2694)
Resumes & cover letters (651)
Rett syndrome (16)
RNA editing (15)
RSV (76)
Schizophrenia (139)
Series A (213)
Series B (159)
Service/supplier (30)
Sickle cell disease (81)
Special edition (26)
Spinal muscular atrophy (170)
Sponsored (41)
Startups (4319)
State (2)
Stomach cancer (17)
Supply chain (102)
Tariffs (96)
The Weekly (111)
Vaccines (1058)
Venture capital (67)
Weight loss (400)
Women's health (60)
Worklife (21)
Date
Today (166)
Last 7 days (756)
Last 30 days (2915)
Last 365 days (33539)
2025 (27455)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1281)
Alabama (80)
Alaska (7)
Arizona (307)
Arkansas (14)
Asia (51031)
Australia (8971)
California (9664)
Canada (2901)
China (927)
Colorado (408)
Connecticut (431)
Delaware (277)
Europe (117254)
Florida (1424)
Georgia (319)
Hawaii (3)
Idaho (67)
Illinois (820)
India (54)
Indiana (479)
Iowa (20)
Japan (330)
Kansas (126)
Kentucky (39)
Louisiana (22)
Maine (78)
Maryland (1294)
Massachusetts (7243)
Michigan (317)
Minnesota (573)
Mississippi (4)
Missouri (123)
Montana (33)
Nebraska (26)
Nevada (109)
New Hampshire (80)
New Jersey (2685)
New Mexico (32)
New York (2622)
North Carolina (1426)
North Dakota (10)
Northern California (4411)
Ohio (304)
Oklahoma (22)
Oregon (51)
Pennsylvania (2005)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (50)
South Dakota (1)
Southern California (3686)
Tennessee (152)
Texas (1523)
United States (35639)
Utah (287)
Virginia (251)
Washington D.C. (84)
Washington State (830)
West Virginia (4)
Wisconsin (98)
Wyoming (1)
There are 861,919 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Microbiome Labs Expands Portfolio with Launch of Women’s Health Line
October 29, 2025
·
2 min read
Biosimilars
FDA Proposes Lower Bar for Biosimilar Approvals in Bid To Lower Drug Prices
Generic versions of biologic drugs could hit the market without human trials and allow the market forces to bring down costs, HHS leaders said while announcing new draft guidance.
October 29, 2025
·
3 min read
·
Dan Samorodnitsky
Immunology and inflammation
Novartis Presents New Data From Potential First Targeted Sjögren’s Treatment
Late-breaking Phase III data show ianalumab, Novartis’ dual-targeted antibody, reduced disease activity and patient burden in Sjögren’s disease, the pharma reported at the American College of Rheumatology Convergence congress on Wednesday.
October 29, 2025
·
3 min read
·
Heather McKenzie
Layoffs
Genentech’s Latest Layoffs Bring Total to Nearly 350 This Year
Genentech is letting go of 118 employees in South San Francisco. The news comes about two months after the biotech ended a partnership with Adaptive Biotechnologies.
October 29, 2025
·
1 min read
·
Angela Gabriel
Earnings
GSK Points to ‘Macro Factors’ To Explain US Shingrix Demand Crash
Shingrix sales in the U.S. took a 15% dive in the third quarter. GSK is now the second Big Pharma to report declining vaccine sales, after
Sanofi reported
a similar decline last week.
October 29, 2025
·
2 min read
·
Tristan Manalac
Clinical research
BridgeBio Shares Pop Again as Phase III Thyroid Drug Exceeds Investor Expectations
Already sky high after the success of its limb-girdle muscular dystrophy therapy, reported on Monday, BridgeBio’s shares rose nearly 8% more as encaleret balanced calcium levels in patients with a genetic thyroid disorder.
October 29, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
Hemostemix Announces Its Webinar for Florida Vascular Surgeons: Autologous Stem Cell Therapy for CLTI
October 29, 2025
·
8 min read
Press Releases
Envoy Medical Marks Three-Year Anniversary of First Patient Receiving Its Breakthrough Fully Implanted Cochlear Implant
The Company looks to build on its recent momentum - receiving FDA approval to expand its pivotal clinical trial into the second and final stage
October 29, 2025
·
9 min read
Press Releases
Olympus Introduces a NBI+TXI™ Observation Mode to the EVIS X1™ Endoscopy System CV-1500 Video System Center
October 29, 2025
·
1 min read
Press Releases
Greenstone Biosciences Advances AI-Driven Human Models for Drug Safety and Efficacy with NVIDIA
October 29, 2025
·
1 min read
1 of 86,192
Next
